Clinical Trials Browser

NCT01814813 2025-01-24

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

Phase 2 Terminated

90 enrolled 13 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT03973918 2024-10-31

BRAF

Phase 2 Terminated

5 enrolled 15 charts

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

NCT00014443 2023-01-09

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Phase 2 Terminated

5 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01822275 2022-12-29

GCC 1224

Phase 2 Terminated

24 enrolled 9 charts

Sarcoma

Gliosarcoma

NCT03641326 2022-04-19

Sunitinib in Sarcomas of the Central Nervous System

Phase 2 Terminated

5 enrolled 14 charts

CNSSarcoma

Brain Neoplasms, Gliosarcoma

NCT02743078 2021-06-02

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

Phase 2 Terminated

3 enrolled 10 charts

CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

NCT00006916 2020-10-26

Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Phase 2 Terminated

19 enrolled 4 charts

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00243022 2019-04-30

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

Phase 2 Terminated

12 enrolled 15 charts

CNSSarcoma

Astrocytoma, Brain Edema, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01186406 2019-02-15

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Phase 2 Terminated

41 enrolled 9 charts

CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

NCT01575275 2018-07-31

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Phase 2 Terminated

8 enrolled 7 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01836549 2018-07-20

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Phase 2 Terminated

43 enrolled 14 charts

CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Oligodendroglioma, Gliosarcoma, Brain Stem Neoplasms

NCT00052715 2018-07-18

Poly-ICLC

Phase 2 Terminated

31 enrolled 8 charts

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00238277 2018-06-27

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Phase 2 Terminated

15 enrolled

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00112866 2017-06-14

Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme

Phase 2 Terminated

30 enrolled 10 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01310855 2017-05-31

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Terminated

38 enrolled 8 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01122901 2017-05-03

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Terminated

47 enrolled 9 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00436436 2017-03-28

O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Phase 2 Terminated

12 enrolled 10 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT02394665 2017-01-05

Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma

Phase 2 Terminated

1 enrolled 3 charts

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT01227434 2015-07-17

PD0332991

Phase 2 Terminated

23 enrolled 8 charts

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

NCT00068770 2015-03-18

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Phase 2 Terminated

35 enrolled 12 charts

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01017653 2013-09-04

Panitumumab and Irinotecan for Malignant Gliomas

Phase 2 Terminated

16 enrolled 9 charts

CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

NCT01095094 2013-06-10

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Phase 2 Terminated

19 enrolled 9 charts

CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00387894 2013-06-04

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Phase 2 Terminated

6 enrolled 10 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00735436 2013-02-11

A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)

Phase 2 Terminated

18 enrolled 11 charts

CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

NCT00075491 2013-01-24

Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme

Phase 2 Terminated

42 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00848523 2010-07-16

Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors

Phase 2 Terminated

6 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00365222 2009-01-22

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Phase 2 Terminated

1 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Neurologic Manifestations, Gliosarcoma